Skip to content
2000
Volume 18, Issue 5
  • ISSN: 1570-1808
  • E-ISSN: 1875-628X

Abstract

The recent pandemic caused by a novel coronavirus known as SARS-CoV-2 has caught the international community by surprise. There is still no effective vaccine or treatment option against this virus. In this perspective, we discussed the potential protective and therapeutic effects of chitosan, as an FDA-approved biomolecule, against COVID-19 and influenza viruses.

Loading

Article metrics loading...

/content/journals/lddd/10.2174/1570180817999201110114446
2021-05-01
2025-09-15
Loading full text...

Full text loading...

/content/journals/lddd/10.2174/1570180817999201110114446
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test